TipRanks
West Pharmaceutical Services, Inc. (DE:WPS)
FRANKFURT:WPS
Germany Market
WPS
West Pharmaceutical Services
RESEARCH TOOLSreports

West Pharmaceutical Services (WPS) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

WPS Analyst Ratings

Strong Buy
10Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
Based on 10 analysts giving stock ratings to
West
Pharmaceutical Services
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WPS Stock 12 Month Forecast

Average Price Target

€353.76
▲(19.43% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for West Pharmaceutical Services in the last 3 months. The average price target is €353.76 with a high forecast of €387.36 and a low forecast of €316.30. The average price target represents a 19.43% change from the last price of €296.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"190":"€190","289":"€289","388":"€388","239.5":"€239.5","338.5":"€338.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":387.36144327,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€387.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":353.7573807044444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€353.76</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":316.30184965,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€316.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[190,239.5,289,338.5,388],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.8,299.15088025153847,306.5017605030769,313.8526407546154,321.20352100615384,328.5544012576923,335.9052815092308,343.25616176076926,350.6070420123077,357.95792226384617,365.3088025153846,372.6596827669231,380.01056301846154,{"y":387.36144327,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.8,296.56595236188036,301.3319047237607,306.097857085641,310.86380944752136,315.6297618094017,320.39571417128207,325.16166653316236,329.9276188950427,334.69357125692306,339.4595236188034,344.2254759806837,348.99142834256406,{"y":353.7573807044444,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.8,293.6847576653846,295.56951533076926,297.45427299615386,299.33903066153846,301.2237883269231,303.1085459923077,304.9933036576923,306.8780613230769,308.76281898846156,310.64757665384616,312.53233431923076,314.4170919846154,{"y":316.30184965,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":208.448,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220.212,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.75,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.354,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.562,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":191.081,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":212.401,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.297,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.531,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.115,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":311.491,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.1,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.8,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€387.36Average Price Target€353.76Lowest Price Target€316.30
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on DE:WPS
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€316.3
Hold
6.79%
Upside
Reiterated
09/14/26
West Pharmaceutical: Hold Rating Reiterated as Robust GLP-1 Demand Meets Fully Valued Shares; Price Target Maintained at $365
UBS Analyst forecast on DE:WPS
Doug Schenkel
UBS
UBS
€294.64→€359.63
Buy
21.41%
Upside
Reiterated
09/09/26
West Pharmaceutical assumed with a Buy at UBSWest Pharmaceutical assumed with a Buy at UBS
Citi Analyst forecast on DE:WPS
Joanne Wuensch
Citi
Citi
€346.63→€357.03
Buy
20.54%
Upside
Reiterated
08/03/26
West Pharmaceutical price target raised to $412 from $400 at CitiWest Pharmaceutical price target raised to $412 from $400 at Citi
Evercore ISI Analyst forecast on DE:WPS
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
€355.3→€368.3
Buy
24.34%
Upside
Reiterated
07/27/26
West Pharmaceutical price target raised to $425 from $410 at Evercore ISIWest Pharmaceutical price target raised to $425 from $410 at Evercore ISI
Barclays Analyst forecast on DE:WPS
Luke Sergott
Barclays
Barclays
€346.63
Buy
17.03%
Upside
Reiterated
07/24/26
West Pharmaceutical Services (WST) Receives a Buy from Barclays
Bank of America Securities Analyst forecast on DE:WPS
Michael Ryskin
Bank of America Securities
Bank of America Securities
€355.3
Buy
19.95%
Upside
Reiterated
07/24/26
West Pharmaceutical price target raised to $410 from $400 at BofAWest Pharmaceutical price target raised to $410 from $400 at BofA
TD Cowen Analyst forecast on DE:WPS
Brendan Smith
TD Cowen
TD Cowen
€316.3→€355.3
Buy
19.95%
Upside
Assigned
07/23/26
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (NYSE: WST) and Thermo Fisher (NYSE: TMO)
William Blair Analyst forecast on DE:WPS
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analyst Reiterates Buy on West as Biologics-Driven Double-Digit Growth, Margin Upside and Conservative Outlook Signal Further Upside Potential
Exane BNP Paribas Analyst forecast on DE:WPS
Curtis Moiles
Exane BNP Paribas
Exane BNP Paribas
€387.36
Buy
30.78%
Upside
Initiated
07/13/26
West Pharmaceutical initiated with an Outperform at BNP ParibasWest Pharmaceutical initiated with an Outperform at BNP Paribas
KeyBanc Analyst forecast on DE:WPS
Paul Knight
KeyBanc
KeyBanc
€303.3→€337.97
Buy
14.10%
Upside
Reiterated
07/02/26
West Pharmaceutical price target raised to $390 from $350 at KeyBancWest Pharmaceutical price target raised to $390 from $350 at KeyBanc
Wolfe Research Analyst forecast on DE:WPS
Michael Polark
Wolfe Research
Wolfe Research
€324.97
Buy
9.71%
Upside
Assigned
06/01/26
West Pharmaceutical assumed at Outperform from Peer Perform at Wolfe ResearchWest Pharmaceutical assumed at Outperform from Peer Perform at Wolfe Research
RBC Capital Analyst forecast on DE:WPS
Dan Leonard
RBC Capital
RBC Capital
€307.64→€294.64
Buy
-0.53%
Downside
Reiterated
02/13/26
West Pharmaceutical price target lowered to $340 from $355 at UBSWest Pharmaceutical price target lowered to $340 from $355 at UBS
Deutsche Bank Analyst forecast on DE:WPS
Justin Bowers
Deutsche Bank
Deutsche Bank
€268.64→€272.97
Buy
-7.84%
Downside
Reiterated
02/13/26
West Pharmaceutical price target raised to $315 from $310 at Deutsche BankWest Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
Jefferies Analyst forecast on DE:WPS
David Windley
Jefferies
Jefferies
€316.3→€255.64
Buy
-13.69%
Downside
Reiterated
02/10/26
Jefferies Keeps Their Buy Rating on West Pharmaceutical Services (WST)
DBS Analyst forecast on DE:WPS
Nico Chen
DBS
DBS
€277.31
Buy
-6.38%
Downside
Reiterated
01/28/26
DBS Sticks to Their Buy Rating for West Pharmaceutical Services (WST)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on DE:WPS
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
€316.3
Hold
6.79%
Upside
Reiterated
09/14/26
West Pharmaceutical: Hold Rating Reiterated as Robust GLP-1 Demand Meets Fully Valued Shares; Price Target Maintained at $365
UBS Analyst forecast on DE:WPS
Doug Schenkel
UBS
UBS
€294.64→€359.63
Buy
21.41%
Upside
Reiterated
09/09/26
West Pharmaceutical assumed with a Buy at UBSWest Pharmaceutical assumed with a Buy at UBS
Citi Analyst forecast on DE:WPS
Joanne Wuensch
Citi
Citi
€346.63→€357.03
Buy
20.54%
Upside
Reiterated
08/03/26
West Pharmaceutical price target raised to $412 from $400 at CitiWest Pharmaceutical price target raised to $412 from $400 at Citi
Evercore ISI Analyst forecast on DE:WPS
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
€355.3→€368.3
Buy
24.34%
Upside
Reiterated
07/27/26
West Pharmaceutical price target raised to $425 from $410 at Evercore ISIWest Pharmaceutical price target raised to $425 from $410 at Evercore ISI
Barclays Analyst forecast on DE:WPS
Luke Sergott
Barclays
Barclays
€346.63
Buy
17.03%
Upside
Reiterated
07/24/26
West Pharmaceutical Services (WST) Receives a Buy from Barclays
Bank of America Securities Analyst forecast on DE:WPS
Michael Ryskin
Bank of America Securities
Bank of America Securities
€355.3
Buy
19.95%
Upside
Reiterated
07/24/26
West Pharmaceutical price target raised to $410 from $400 at BofAWest Pharmaceutical price target raised to $410 from $400 at BofA
TD Cowen Analyst forecast on DE:WPS
Brendan Smith
TD Cowen
TD Cowen
€316.3→€355.3
Buy
19.95%
Upside
Assigned
07/23/26
Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (NYSE: WST) and Thermo Fisher (NYSE: TMO)
William Blair Analyst forecast on DE:WPS
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analyst Reiterates Buy on West as Biologics-Driven Double-Digit Growth, Margin Upside and Conservative Outlook Signal Further Upside Potential
Exane BNP Paribas Analyst forecast on DE:WPS
Curtis Moiles
Exane BNP Paribas
Exane BNP Paribas
€387.36
Buy
30.78%
Upside
Initiated
07/13/26
West Pharmaceutical initiated with an Outperform at BNP ParibasWest Pharmaceutical initiated with an Outperform at BNP Paribas
KeyBanc Analyst forecast on DE:WPS
Paul Knight
KeyBanc
KeyBanc
€303.3→€337.97
Buy
14.10%
Upside
Reiterated
07/02/26
West Pharmaceutical price target raised to $390 from $350 at KeyBancWest Pharmaceutical price target raised to $390 from $350 at KeyBanc
Wolfe Research Analyst forecast on DE:WPS
Michael Polark
Wolfe Research
Wolfe Research
€324.97
Buy
9.71%
Upside
Assigned
06/01/26
West Pharmaceutical assumed at Outperform from Peer Perform at Wolfe ResearchWest Pharmaceutical assumed at Outperform from Peer Perform at Wolfe Research
RBC Capital Analyst forecast on DE:WPS
Dan Leonard
RBC Capital
RBC Capital
€307.64→€294.64
Buy
-0.53%
Downside
Reiterated
02/13/26
West Pharmaceutical price target lowered to $340 from $355 at UBSWest Pharmaceutical price target lowered to $340 from $355 at UBS
Deutsche Bank Analyst forecast on DE:WPS
Justin Bowers
Deutsche Bank
Deutsche Bank
€268.64→€272.97
Buy
-7.84%
Downside
Reiterated
02/13/26
West Pharmaceutical price target raised to $315 from $310 at Deutsche BankWest Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
Jefferies Analyst forecast on DE:WPS
David Windley
Jefferies
Jefferies
€316.3→€255.64
Buy
-13.69%
Downside
Reiterated
02/10/26
Jefferies Keeps Their Buy Rating on West Pharmaceutical Services (WST)
DBS Analyst forecast on DE:WPS
Nico Chen
DBS
DBS
€277.31
Buy
-6.38%
Downside
Reiterated
01/28/26
DBS Sticks to Their Buy Rating for West Pharmaceutical Services (WST)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ARWRArrowhead Pharmaceuticals
XENEXenon
ATECAlphatec Holdings
PTGXProtagonist Therapeutics
KNSAKiniksa Pharmaceuticals
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering West Pharmaceutical Services

3 Months
Matt LarewWilliam Blair
Success Rate
7/10 ratings generated profit
70%
Average Return
+13.02%
Copying Matt Larew's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +13.02% per trade.
1 Year
Dan LeonardRBC Capital
Success Rate
5/6 ratings generated profit
83%
Average Return
+13.77%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +13.77% per trade.
2 Years
Dan LeonardRBC Capital
Success Rate
6/6 ratings generated profit
100%
Average Return
+34.15%
Copying Dan Leonard's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +34.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WPS Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
1
0
0
0
0
Buy
9
11
17
14
12
Hold
7
8
5
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
19
22
16
14
In the current month, WPS has received 12 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. WPS average Analyst price target in the past 3 months is 353.76.
Each month's total comprises the sum of three months' worth of ratings.

WPS Financial Forecast

WPS Earnings Forecast

Next quarter’s earnings estimate for WPS is €1.89 with a range of €1.86 to €1.92. The previous quarter’s EPS was €2.04. WPS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WPS has Performed in-line its overall industry.
Next quarter’s earnings estimate for WPS is €1.89 with a range of €1.86 to €1.92. The previous quarter’s EPS was €2.04. WPS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year WPS has Performed in-line its overall industry.

WPS Sales Forecast

Next quarter’s sales forecast for WPS is €710.09M with a range of €705.81M to €713.29M. The previous quarter’s sales results were €750.00M. WPS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WPS has Performed in-line its overall industry.
Next quarter’s sales forecast for WPS is €710.09M with a range of €705.81M to €713.29M. The previous quarter’s sales results were €750.00M. WPS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year WPS has Performed in-line its overall industry.

WPS Stock Forecast FAQ

What is DE:WPS’s average 12-month price target, according to analysts?
Based on analyst ratings, West Pharmaceutical Services, Inc.’s 12-month average price target is 353.76.
    What is DE:WPS’s upside potential, based on the analysts’ average price target?
    West Pharmaceutical Services, Inc. has 19.43% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is West Pharmaceutical Services, Inc. a Buy, Sell or Hold?
          West Pharmaceutical Services, Inc. has a consensus rating of Strong Buy, which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
            What is West Pharmaceutical Services, Inc.’s share price target?
            The average share price target for West Pharmaceutical Services, Inc. is 353.76. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €387.36 ,and the lowest forecast is €316.30. The average share price target represents 19.43% Increase from the current price of €296.2.
              What do analysts say about West Pharmaceutical Services, Inc.?
              West Pharmaceutical Services, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of West Pharmaceutical Services, Inc.?
                To buy shares of DE:WPS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.